Smith Asset Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
112,724
-2,537
-2% -$50K 1.95% 22
2026
Q1
$2.05M Sell
115,261
-1,799
-2% -$34K 1.76% 23
2025
Q4
$2.22M Sell
117,060
-285
-0.2% -$5.38K 1.83% 23
2025
Q3
$2.17M Sell
117,345
-2,175
-2% -$35.5K 1.85% 24
2025
Q2
$1.85M Sell
119,520
-1,199
-1% -$18.6K 1.6% 27
2025
Q1
$1.96M Sell
120,719
-2,362
-2% -$40.6K 1.85% 23
2024
Q4
$1.98M Buy
+123,081
New +$2.18M 1.92% 19

Other funds holding HQH

Smith Asset Management's HQH Position: Q2 2026 in Review

Smith Asset Management reduced its abrdn Healthcare Investors (HQH) stake by 2.2% in Q2 2026, selling an estimated $50K and leaving 112,724 shares worth $2.48M. The position accounts for 1.95% of the portfolio, ranked #22.

Smith Asset Management first reported a position in HQH in Q4 2024 and has held it in 7 quarters since. 12 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Smith Asset Management held 112,724 shares of abrdn Healthcare Investors worth $2.48M as of Q2 2026.
  • Smith Asset Management sold 2,537 abrdn Healthcare Investors shares in Q2 2026, an estimated $50K.
  • abrdn Healthcare Investors made up 1.95% of Smith Asset Management's portfolio in Q2 2026, its #22 holding.
  • Smith Asset Management first reported a position in abrdn Healthcare Investors in Q4 2024 and has held it in 7 quarters since.
  • 12 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Smith Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.